Class IITerminatedD-1850-2019
Drug recall · September 18, 2019
Bevacizumab recall
Why: Lack of assurance of sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
- Lots / codes
All lots remaining within expiry.
- Company
- Pacifico National, Inc. dba AmEx Pharmacy, Melbourne, FL
- Distribution
- Continental U.S. and Puerto Rico
- Initiated
- August 30, 2019 · Voluntary: Firm initiated
- Classified
- September 10, 2019
- Reported
- September 18, 2019
- Ended
- October 8, 2020
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.